rs1400667054

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000521.4(HEXB):​c.14G>A​(p.Gly5Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000937 in 1,388,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Synonymous variant affecting the same amino acid position (i.e. G5G) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000094 ( 0 hom. )

Consequence

HEXB
NM_000521.4 missense

Scores

2
4
10

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: -0.0440

Publications

1 publications found
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
HEXB Gene-Disease associations (from GenCC):
  • Sandhoff disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11458337).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEXBNM_000521.4 linkc.14G>A p.Gly5Glu missense_variant Exon 1 of 14 ENST00000261416.12 NP_000512.2 P07686A0A024RAJ6
HEXBNM_001292004.2 linkc.-376-4054G>A intron_variant Intron 1 of 13 NP_001278933.1 P07686Q5URX0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEXBENST00000261416.12 linkc.14G>A p.Gly5Glu missense_variant Exon 1 of 14 1 NM_000521.4 ENSP00000261416.7 P07686

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD2 exomes
AF:
0.00000719
AC:
1
AN:
139060
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000186
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000937
AC:
13
AN:
1388096
Hom.:
0
Cov.:
30
AF XY:
0.0000131
AC XY:
9
AN XY:
685594
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31012
American (AMR)
AF:
0.00
AC:
0
AN:
36358
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24948
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35746
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79394
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37830
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4270
European-Non Finnish (NFE)
AF:
0.0000120
AC:
13
AN:
1080814
Other (OTH)
AF:
0.00
AC:
0
AN:
57724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.444
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Sandhoff disease Uncertain:1
Aug 15, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.042
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
18
DANN
Benign
0.97
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0075
N
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.11
T
MetaSVM
Uncertain
-0.0089
T
PhyloP100
-0.044
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.18
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.20
MutPred
0.39
Loss of sheet (P = 0.0181);
MVP
0.76
MPC
0.23
ClinPred
0.12
T
GERP RS
-0.24
PromoterAI
-0.037
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.50
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1400667054; hg19: chr5-73981099; API